April 6, 2022

Pharma
April 6, 2022
Experts Eye a New Game Plan for COVID Vaccines
April 4, 2022
Drug Shortages Persist in Russia After Start of Ukraine War
April 4, 2022
Mixed Results for Oregon’s Pioneering Drug Decriminalization
April 4, 2022
Pills Are the Next Big Abortion Battleground
April 4, 2022
Why So Many Women in Middle Age Are on Antidepressants
April 1, 2022
‘Recognition of Failure’: A Shift Urged in Global Vaccination Strategy
March 31, 2022
Cautious Optimism for Trials of mRNA-Based HIV Vaccine
March 31, 2022
Despite Doctors’ Concerns, Pharmacists Get More Leeway to Offer Treatment with Testing
March 31, 2022
Califf Admits Controversy Over FDA’s Alzheimer’s Drug Decision Impacted Expert’s Trust in the Agency
March 31, 2022
PLoS One Pulls Five Papers Tied to Alzheimer’s Drug Controversy
March 31, 2022
Metformin Prescriptions Linked to Son’s Birth Defects
March 31, 2022
Novavax Asks EU Regulator to Clear COVID Vaccine for Teens
March 31, 2022
Study: Ivermectin Does Not Prevent COVID-19 Hospitalization
March 31, 2022
44 Countries Have COVID Vaccination Rates Under 20% Despite Supply Increase
March 30, 2022
America’s Choose-Your-Own-Adventure Vaccine Approach
March 29, 2022
Why Kids’ COVID Vaccines Aren’t Performing Like Adults’
March 29, 2022
US-Backed Group Gets Lifesaving Meds to Ukrainians Amid War
March 29, 2022
CDC Recommends Second Booster Shot for Americans Over 50
March 28, 2022
Public Health Catastrophe Looms in Ukraine, Experts Warn
March 28, 2022
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
March 28, 2022
FDA Skeptical of Benefits from Experimental ALS Drug
March 28, 2022
The FDA Is Expected to Authorize 2nd Boosters for People 50 and Up
March 25, 2022
FDA Rejects Eli Lilly’s China-Developed Cancer Drug
March 24, 2022